Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

80.84
Delayed Data
As of Jun 14
 -1.52 / -1.85%
Today’s Change
79.13
Today|||52-Week Range
106.74
-5.06%
Year-to-Date

Today’s Trading

Previous close82.36
Today’s open82.12
Day’s range80.54 - 83.03
Volume773,273
Average volume (3 months)1,211,069
Market cap$14.5B
Data as of 4:00pm ET, 06/14/2019

Growth & Valuation

Earnings growth (last year)+34.91%
Earnings growth (this year)-8.73%
Earnings growth (next 5 years)+50.30%
Revenue growth (last year)+13.51%
P/E ratioNM
Price/Sales10.07
Price/Book4.86

Competitors

 Today’s
change
Today’s
% change
INCYIncyte Corp+1.34+1.75%
SGENSeattle Genetics Inc-0.46-0.67%
SAGESAGE Therapeutics In...-1.58-0.90%
SRPTSarepta Therapeutics...-3.64-2.95%
Data as of 4:00pm ET, 06/14/2019

Financials

Next reporting dateAugust 5, 2019
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$1.5B
Annual profit (last year)-$77.2M
Net profit margin-5.16%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Dan Spiegelman
Corporate headquarters
San Rafael, California

Forecasts